These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
247 related articles for article (PubMed ID: 9673532)
1. The effects of L-carnitine on respiratory function tests in children undergoing chronic hemodialysis. Kavukçu S; Türkmen M; Salman S; Onvural B; Oktay G; Karaman O; Cevik NT Turk J Pediatr; 1998; 40(1):79-84. PubMed ID: 9673532 [TBL] [Abstract][Full Text] [Related]
2. The effects of L-carnitine therapy on respiratory function tests in chronic hemodialysis patients. Bavbek N; Akay H; Uz B; Uz E; Turgut F; Kanbay M; Senes M; Akcay A; Duranay M Ren Fail; 2010 Jan; 32(2):157-61. PubMed ID: 20199175 [TBL] [Abstract][Full Text] [Related]
3. The evaluation of postdialysis L-carnitine administration and its effect on weekly requiring doses of rHuEPO in hemodialysis patients. Kadiroglu AK; Yilmaz ME; Sit D; Kara IH; Isikoglu B Ren Fail; 2005; 27(4):367-72. PubMed ID: 16060121 [TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of L-carnitine in patients with end-stage renal disease undergoing long-term hemodialysis. Evans AM; Faull R; Fornasini G; Lemanowicz EF; Longo A; Pace S; Nation RL Clin Pharmacol Ther; 2000 Sep; 68(3):238-49. PubMed ID: 11014405 [TBL] [Abstract][Full Text] [Related]
5. Effect of dialysate composition on the lipid response to L-carnitine supplementation. Zilleruelo G; Novak M; Hsia SL; Goldberg R; Abitbol C; Monkus E; Strauss J Kidney Int Suppl; 1989 Nov; 27():S259-63. PubMed ID: 2699997 [TBL] [Abstract][Full Text] [Related]
6. Effects of carnitine supplementation on muscle metabolism by the use of magnetic resonance spectroscopy and near-infrared spectroscopy in end-stage renal disease. Vaux EC; Taylor DJ; Altmann P; Rajagopalan B; Graham K; Cooper R; Bonomo Y; Styles P Nephron Clin Pract; 2004; 97(2):c41-8. PubMed ID: 15218329 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of the effect of intravenous l-carnitine on quality of life in chronic hemodialysis patients. Semeniuk J; Shalansky KF; Taylor N; Jastrzebski J; Cameron EC Clin Nephrol; 2000 Dec; 54(6):470-7. PubMed ID: 11140808 [TBL] [Abstract][Full Text] [Related]
8. L-carnitine supplementation and adipokines in patients with end-stage renal disease on regular hemodialysis. Csiky B; Nyul Z; Tóth G; Wittmann I; Melegh B; Rauh M; Rascher W; Sulyok E Exp Clin Endocrinol Diabetes; 2010 Nov; 118(10):735-40. PubMed ID: 20658442 [TBL] [Abstract][Full Text] [Related]
9. [Effect of L-carnitine supplementation on lipid metabolism of renal failure, dialysis-dependent children and adolescents]. Böhles H; Michalk D; von Wendt-Göknur E Infusionstherapie; 1991 Oct; 18(5):224-6. PubMed ID: 1769735 [TBL] [Abstract][Full Text] [Related]
10. Effect of chronic renal hemodialysis on serum total, free and acyl carnitine concentrations in adult chronic pyelonephritis patients. Alhomida AS Arch Med Res; 1997; 28(1):101-7. PubMed ID: 9078596 [TBL] [Abstract][Full Text] [Related]
11. Effects of L-carnitine on leukocyte function and viability in hemodialysis patients: A double-blind randomized trial. Thomas S; Fischer FP; Mettang T; Pauli-Magnus C; Weber J; Kuhlmann U Am J Kidney Dis; 1999 Oct; 34(4):678-87. PubMed ID: 10516349 [TBL] [Abstract][Full Text] [Related]
12. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis. Brandi L Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159 [TBL] [Abstract][Full Text] [Related]
13. Carnitine replacement in end-stage renal disease and hemodialysis. Calvani M; Benatti P; Mancinelli A; D'Iddio S; Giordano V; Koverech A; Amato A; Brass EP Ann N Y Acad Sci; 2004 Nov; 1033():52-66. PubMed ID: 15591003 [TBL] [Abstract][Full Text] [Related]
14. Close association between parathyroid hormone and left ventricular function and structure in end-stage renal failure patients under maintenance hemodialysis. Nasri H; Baradaran A; Naderi AS Acta Med Austriaca; 2004 Aug; 31(3):67-72. PubMed ID: 15515479 [TBL] [Abstract][Full Text] [Related]
15. Fatty acid abnormalities in hemodialysis patients: effect of L-carnitine administration. Ahmad S; Dasgupta A; Kenny MA Kidney Int Suppl; 1989 Nov; 27():S243-6. PubMed ID: 2636665 [TBL] [Abstract][Full Text] [Related]
16. Close association between parathyroid hormone and left ventricular function and structure in end-stage renal failure patients under maintenance hemodialysis. Nasri H; Baradaran A J Ayub Med Coll Abbottabad; 2004; 16(2):3-8. PubMed ID: 15455608 [TBL] [Abstract][Full Text] [Related]
17. [Secondary L-carnitine deficiency in chronic hemodialysis patients]. Achenbach H; Würzberger G; Seim H; Löster H; Strauss B Z Gesamte Inn Med; 1989 Jan; 44(1):18-22. PubMed ID: 2711712 [TBL] [Abstract][Full Text] [Related]
18. Advances in carnitine in chronic uremia. Guarnieri G; Biolo G; Vinci P; Massolino B; Barazzoni R J Ren Nutr; 2007 Jan; 17(1):23-9. PubMed ID: 17198928 [TBL] [Abstract][Full Text] [Related]
19. [Effects of long-term treatment with L-carnitine on dyslipemia in hemodialysis patients]. Dionisio P; Bergia R; Caramello E; Graziola M; Valenti M; Bajardi P; Barbera L; Voglino F Minerva Med; 1985 Feb; 76(6):229-34. PubMed ID: 3974937 [TBL] [Abstract][Full Text] [Related]
20. The effect of long-term intravenous high dose B-complex vitamins with or without folic acid on serum homocysteine in hemodialysis patients. Sombolos K; Fragia T; Natse T; Bartholomatos G; Karagianni A; Katsaris G; Christidou F; Bamichas G; Stangou M; Papagalanis N J Nephrol; 2002; 15(6):671-5. PubMed ID: 12495282 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]